MyoKardia Inc - Company & Market Research Reports

MyoKardia is a clinical stage biopharmaceutical company that develops therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). MyoKardia, Inc. was founded in 2012 and is headquartered in South San Francisco, California.

2018 Hypertrophic Cardiomyopathy Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Hypertrophic Cardiomyopathy Market - Product Thumbnail Image

2018 Hypertrophic Cardiomyopathy Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Hypertrophic Cardiomyopathy Market

  • Report
  • 70 Pages
From
2018 Dilated Cardiomyopathy Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Dilated Cardiomyopathy Market - Product Thumbnail Image

2018 Dilated Cardiomyopathy Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Dilated Cardiomyopathy Market

  • Report
  • 70 Pages
From
Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 58 Pages
From
Cardiomyopathy Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Cardiomyopathy Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 198 Pages
From
Asia Pacific Dilated Cardiomyopathy Market - Opportunities and Forecasts, 2017 - 2023 - Product Thumbnail Image

Asia Pacific Dilated Cardiomyopathy Market - Opportunities and Forecasts, 2017 - 2023

  • Report
From
Dilated Cardiomyopathy - Pipeline Review, H2 2018 - Product Thumbnail Image

Dilated Cardiomyopathy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 65 Pages
From
Hypertrophic Cardiomyopathy - Pipeline Review, H1 2018 - Product Thumbnail Image

Hypertrophic Cardiomyopathy - Pipeline Review, H1 2018

  • Drug Pipelines
  • 48 Pages
From
Dilated Cardiomyopathy - Pipeline Insight, 2018 - Product Thumbnail Image

Dilated Cardiomyopathy - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
MYK-461 Phase II Trial Results Call - MyoKardia, Inc., - Earnings Transcript - Product Thumbnail Image

MYK-461 Phase II Trial Results Call - MyoKardia, Inc., - Earnings Transcript

  • Earnings Transcript
MyoKardia Inc (MYOK) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

MyoKardia Inc (MYOK) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 43 Pages
From
Myokardia Inc - Product Thumbnail Image

Myokardia Inc

  • Company Profile
  • 61 Pages
MyoKardia Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

MyoKardia Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
Q2 2018 Earnings Call - MyoKardia, Inc., - Earnings Transcript - Product Thumbnail Image

Q2 2018 Earnings Call - MyoKardia, Inc., - Earnings Transcript

  • Earnings Transcript
Q1 2018 Earnings Call - MyoKardia, Inc., - Earnings Transcript - Product Thumbnail Image

Q1 2018 Earnings Call - MyoKardia, Inc., - Earnings Transcript

  • Earnings Transcript
Q4 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript

  • Earnings Transcript
MyoKardia Inc Strategic Analysis Review - MyoKardia Inc SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

MyoKardia Inc Strategic Analysis Review - MyoKardia Inc SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Q3 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript - Product Thumbnail Image

Q3 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript

  • Earnings Transcript
Q2 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript - Product Thumbnail Image

Q2 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript

  • Earnings Transcript
Q1 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript - Product Thumbnail Image

Q1 2017 Earnings Call - MyoKardia, Inc., - Earnings Transcript

  • Earnings Transcript
MyoKardia, Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

MyoKardia, Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 20 Results (Page 1 of 1)
Loading Indicator
adroll